# India is set to get its first mRNA vaccine, albeit through a donation, from Moderna. And drugmaker Cipla will facilitate the through-pass. That said, it paves the way for more strategic partnerships to bring next-gen vaccines into the country.
# Staying with vaccines, Indian Immunologicals makes progress with its Covid-19 vaccine, as it seeks regulatory approvals for early phase human trials.
# The EU “green-pass” has been causing much heartburn for Indians vaccinated with Serum Institute’s Covishield. But here’s a clarification from official sources.
# And here’s what the European regulatory authority on medicines and vaccines has to say on it. Unnecessary anxiety, say industry-insiders, specially when Covishield is deployed in the UK and has a WHO listing for emergency use as well.
# Domestic pharma majors explore collaborative research on a Covid-19 drug. A first time for the sector, heralds interesting times ahead ....